Haneesha Mohan
Overview
Explore the profile of Haneesha Mohan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
252
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mohan H, Nguyen J, MacKenzie B, Yee A, Laurette E, Sanghvi T, et al.
EBioMedicine
. 2023 Aug;
95:104762.
PMID: 37586112
Background: Dolutegravir (DTG) is a recommended first-line regimen for all people with Human Immunodeficiency Virus (HIV) infection. Initial findings from Botswana, a country with no folate fortification program, showed an...
2.
Dontsova V, Mohan H, Blanco C, Jao J, Greene N, Copp A, et al.
Lancet HIV
. 2023 Aug;
10(9):e606-e616.
PMID: 37549681
Dolutegravir is recommended for all people living with HIV because of its efficacy, high barrier to resistance, favourable safety and tolerability profile, and affordability. Dolutegravir has the highest rates of...
3.
A Pharmacokinetic Dose-Optimization Study of Cabotegravir and Bictegravir in a Mouse Pregnancy Model
Mohan H, Atkinson K, Watson B, Brumme C, Serghides L
Pharmaceutics
. 2022 Sep;
14(9).
PMID: 36145509
Animal pregnancy models can be useful tools to study HIV antiretroviral safety and toxicity and to perform mechanistic studies that are not easily performed in humans. Utilization of clinically relevant...
4.
Smith M, Mohan H, Ajaykumar A, Hsieh A, Martineau L, Patel R, et al.
J Infect Dis
. 2022 Sep;
226(11):1992-2001.
PMID: 36124861
Background: Each year, approximately 1.1 million children are exposed in utero to human immunodeficiency virus antiretrovirals, yet their safety is often not well characterized during pregnancy. The Tsepamo study reported...
5.
Gilmore J, Hoque M, Dai W, Mohan H, Dunk C, Serghides L, et al.
EBioMedicine
. 2021 Dec;
75:103771.
PMID: 34954655
Background: Due to the critical role of folates in neurodevelopment, it is important to understand potential interactions between anti-HIV drugs used during pregnancy, and folate delivery pathways in the placenta....
6.
Chalmers J, Dalvi P, Loganathan N, McIlwraith E, Wellhauser L, Nazarians-Armavil A, et al.
Endocrinology
. 2021 Dec;
163(1).
PMID: 34919671
MicroRNAs (miRNAs) expressed in the hypothalamus are capable of regulating energy balance and peripheral metabolism by inhibiting translation of target messenger RNAs (mRNAs). Hypothalamic insulin resistance is known to precede...
7.
Copp A, Greene N, Jao J, Zash R, Mohan H, Dontsova V, et al.
Birth Defects Res
. 2021 Dec;
114(1):23-24.
PMID: 34851540
No abstract available.
8.
Al Rijjal D, Liu Y, Lai M, Song Y, Danaei Z, Wu A, et al.
iScience
. 2021 Aug;
24(8):102909.
PMID: 34458694
Omega-3 fatty acid prescription drugs, Vascepa (≥96% eicosapentaenoic acid [EPA] ethyl ester) and Lovaza (46.5% EPA and 37.5% docosahexaenoic acid ethyl ester) are known therapeutic regimens to treat hypertriglyceridemia. However,...
9.
Mohan H, Lenis M, Laurette E, Tejada O, Sanghvi T, Leung K, et al.
EBioMedicine
. 2020 Dec;
63:103167.
PMID: 33341441
Background: Dolutegravir (DTG) is a preferred regimen for all people with HIV including pregnant women, but its effects on the fetus are not fully understood. Periconceptional exposure to DTG has...
10.
Khan S, Mohan H, Liu Y, Batchuluun B, Gohil H, Al Rijjal D, et al.
Diabetologia
. 2019 Feb;
62(4):730-731.
PMID: 30734838
Unfortunately, the graph in Fig. 5f became misaligned during typesetting.